Health Canada drug identification number

DIN 02473550 — ADDYI 100 MG

ADDYI is a tablet of Flibanserin marketed by SPROUT PHARMACEUTICALS INC. The full Flibanserin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02473550
Brand name
ADDYI
Active ingredient
Flibanserin
Strength
100 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
SPROUT PHARMACEUTICALS INC
Health Canada status
MARKETED
Drug class
Central nervous system agent (serotonin 5-HT1A agonist / 5-HT2A antagonist)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.